Figure 1.
FTO is overexpressed in metastatic EC cancer. (A) FTO mRNA expression in metastatic EC (N = 30) and nonmetastatic EC tissues (N = 66). (B) Expression of the FTO protein in nonmetastatic EC tissue and different types of metastatic EC tissues. (C) The IHC score of the FTO protein in different EC samples, (No metastasis, N = 66), (With metastasis, N = 30), (Abdominal metastasis, N = 24), (Lymph node metastasis, N = 22). **P < 0.01, n.s indicates not significant